Current State of Immunotherapy for Treatment of Glioblastoma

Current Treatment Options in Oncology - United States
doi 10.1007/s11864-019-0619-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Current Studies of Immunotherapy on Glioblastoma

Journal of Neurology and Neurosurgery
2014English

Current Developments in Immunotherapy in the Treatment of Multiple Myeloma

Cancer
Cancer ResearchOncology
2018English

T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Beyond Monotherapy: Integrating Immunotherapy Into Current Treatment Regimens

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

NK Cell-Based Glioblastoma Immunotherapy

Cancers
Cancer ResearchOncology
2018English

Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Commentary: Current Status of Intratumoral Therapy for Glioblastoma

Journal of Neurology and Neuromedicine
2016English

EnLIGHTenment of Tumor Vessel Normalization and Immunotherapy in Glioblastoma

Journal of Pathology
Forensic MedicinePathology
2018English

T-Cell Apoptosis in Human Glioblastoma Multiforme: Implications for Immunotherapy

Journal of Neuroimmunology
AllergyImmunologyNeurology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy